Why is Injective price down today?

Traders Union
All News
Crypto News
Injective slides 10.29% today to $4.59

Highlights

INJ futures are now listed on Bitnomial Exchange, expanding U.S. regulated access under CFTC oversight for institutional and retail traders.
This integration into compliant trading infrastructure reinforces Injective's positioning within decentralized finance, despite current price pressures.
Technicals show mixed momentum and heavy intraday selling, with INJ/USD expected to consolidate between $4.22 and $5.14 over the next week; risk of downside prevails unless $5.14 breaks.

Regulated futures listing grows access amid persistent selling pressure

Injective expanded its presence in the U.S. regulated futures market, with INJ futures now available for trading on the Bitnomial Exchange, a platform regulated by the Commodity Futures Trading Commission. This launch grants U.S. institutions and retail traders regulated derivatives access to Injective and further embeds the asset into compliant trading infrastructure. The move highlights Injective’s blockchain architecture, supporting its role in decentralized finance and institutional trading, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, highlights that despite INJ trading above key moving averages, the sharp 10.29% drop exposes fragility in sentiment. He notes that overbought signals from the RSI and CCI, aligned with a downside gap, warn of exhaustion after a bullish streak. Kharitonov cautions that continued volatility and intraday selling point to swift reversals even as buyers have dominated so far. He sees the Bitnomial news as supportive long-term, but views immediate price action as increasingly vulnerable. "Momentum remains bullish in structure, but traders should prepare for an extended pullback if the $4.22 support fails," he says.

Viktoras Karapetjanc, expert at Traders Union, sees the recent inclusion of INJ futures on a U.S.-regulated platform as a major step for institutional and retail adoption. He believes the bullish structure remains intact above long-term averages, despite the current dip. Karapetjanc underscores the positive regulatory tone and growing compliant infrastructure supporting further growth. He emphasizes the broader opportunity for Injective to gain traction in decentralized finance as investor access increases. "Regulatory integration and a firmly bullish structure suggest the market offers multiple setups for further gains," he says.

Mixed overbought signals as dynamic support shapes momentum divergence

INJ/USD is currently trading above its 20-day ($4.08) and 50-day ($3.46) simple moving averages, as well as the 200-day ($4.40) level, which confirms a predominantly bullish structure in the short- and medium-term. The nearest dynamic support is indicated by the Ichimoku Kijun at $4.64, with the 50-day moving average acting as additional support if price slips below this level. Momentum signals are mixed on the daily chart: the Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) both show bullish momentum, but the Relative Strength Index (RSI) is firmly in overbought territory, while the Commodity Channel Index (CCI) also signals overbought conditions. The Stochastic RSI points to strong selling pressures, and Bull/Bear Power (BBP) at 0.83 suggests buyers are still dominating, but it also registers as overbought. The Awesome Oscillator’s positive direction lends further support to upward trends. On the session, the pair is under pressure after opening with a downside gap of about $0.24. It is now trading near the low of its daily range at $4.59, slipping 10.29% from the previous close on heightened volatility at 8.08%. Oscillators are flashing warnings of exhaustion, reflecting a divergence from still-bullish momentum and strong selling intraday.

Earlier, analysts noted that Injective maintained a broadly bullish technical structure but faced waning buyer conviction amid heightened volatility and overbought signals. With new regulatory-driven developments now providing institutional access while technical momentum remains mixed, traders should watch for a potential directional shift if the $4.22 support or $5.14 resistance is breached in the days ahead.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.